NCICancerTrials(@NCICancerTrials) 's Twitter Profileg
NCICancerTrials

@NCICancerTrials

Official NCI information about clinical trials for patients with cancer. Follows and retweets are not endorsements. Privacy: https://t.co/QIaGUMSD2j

ID:743479694012592128

linkhttp://www.cancer.gov/clinicaltrials calendar_today16-06-2016 16:25:47

2,2K Tweets

5,8K Followers

266 Following

NCICancerTrials(@NCICancerTrials) 's Twitter Profile Photo

The fusion protein that drives the growth and survival of some rhabdomyosarcoma tumors relies on the KDM4B enzyme, researchers found. Treating mice with a KDM4B-blocking drug and chemotherapy nearly eliminated rhabdomyosarcoma tumors with this protein. cancer.gov/news-events/ca…

The fusion protein that drives the growth and survival of some rhabdomyosarcoma tumors relies on the KDM4B enzyme, researchers found. Treating mice with a KDM4B-blocking drug and chemotherapy nearly eliminated rhabdomyosarcoma tumors with this protein. cancer.gov/news-events/ca…
account_circle
NCICancerTrials(@NCICancerTrials) 's Twitter Profile Photo

Regular visits and calls from community health workers resulted in multiple benefits for those with advanced cancers, from greater use of to decreased hospital visits and improved quality of life. Read more from this new study: cancer.gov/news-events/ca…

Regular visits and calls from community health workers resulted in multiple benefits for those with advanced cancers, from greater use of #PalliativeCare to decreased hospital visits and improved quality of life. Read more from this new study: cancer.gov/news-events/ca… #CancerCare
account_circle
NCICancerTrials(@NCICancerTrials) 's Twitter Profile Photo

Every person’s cancer is different. There’s no guarantee a given treatment is going to work. But a team of researchers hope to soon offer a new tool to guide treatment choices for their patients, based on results from a small study-cancer.gov/news-events/ca…

Every person’s cancer is different. There’s no guarantee a given treatment is going to work. But a team of researchers hope to soon offer #oncologists a new tool to guide treatment choices for their patients, based on results from a small study-cancer.gov/news-events/ca… #OncTwitter
account_circle
NCICancerTrials(@NCICancerTrials) 's Twitter Profile Photo

A combination of the targeted drugs dabrafenib (Tafinlar) and trametinib (Mekinist) has been approved for nearly any type of advanced solid tumor with a specific mutation in the BRAF gene. NCI-MATCH data helped to inform the approval. cancer.gov/news-events/ca…

A combination of the targeted drugs dabrafenib (Tafinlar) and trametinib (Mekinist) has been approved for nearly any type of advanced solid tumor with a specific mutation in the BRAF gene. NCI-MATCH #ClinicalTrial data helped to inform the approval. cancer.gov/news-events/ca…
account_circle
NCICancerTrials(@NCICancerTrials) 's Twitter Profile Photo

NCI researchers are developing an that involves injecting protein bits from cytomegalovirus (CMV) into tumors. In mice, the treatment shrank tumors and kept them from returning. cancer.gov/news-events/ca… @nciresearchctr

NCI researchers are developing an #immunotherapy that involves injecting protein bits from cytomegalovirus (CMV) into tumors. In mice, the treatment shrank tumors and kept them from returning. cancer.gov/news-events/ca… @nciresearchctr
account_circle
NCICancerTrials(@NCICancerTrials) 's Twitter Profile Photo

The drug atezolizumab (Tecentriq) is an additional, or adjuvant, treatment after surgery and chemotherapy for some patients with lung cancer. cancer.gov/news-events/ca…

The #immunotherapy drug atezolizumab (Tecentriq) is an additional, or adjuvant, treatment after surgery and chemotherapy for some patients with lung cancer. #LCAM #WorldLungCancerDay cancer.gov/news-events/ca…
account_circle
NCICancerTrials(@NCICancerTrials) 's Twitter Profile Photo

Men with metastatic don’t live as long as women, and their tumors are more likely to become resistant to commonly used treatments. A new study may help to explain why. cancer.gov/news-events/ca…

Men with metastatic #melanoma don’t live as long as women, and their tumors are more likely to become resistant to commonly used treatments. A new study may help to explain why. cancer.gov/news-events/ca…
account_circle
NCICancerTrials(@NCICancerTrials) 's Twitter Profile Photo

A new study by @nciresearchctr investigators shows how an enzyme can disentangle strands of DNA and RNA. ccr.cancer.gov/news/article/s…

A new study by @nciresearchctr investigators shows how an enzyme can disentangle strands of DNA and RNA. ccr.cancer.gov/news/article/s…
account_circle
NCICancerTrials(@NCICancerTrials) 's Twitter Profile Photo

People with cancer who take drugs often develop skin , including itching and painful rashes. New research in mice suggests these side effects may be caused by the immune system attacking new bacterial colonies on the skin. cancer.gov/news-events/ca…

People with cancer who take #immunotherapy drugs often develop skin #SideEffects, including itching and painful rashes. New research in mice suggests these side effects may be caused by the immune system attacking new bacterial colonies on the skin. cancer.gov/news-events/ca…
account_circle
NCICancerTrials(@NCICancerTrials) 's Twitter Profile Photo

New findings from a large clinical trial could help doctors and patients select treatments for relapsed or treatment-resistant Ewing , a rare cancer that forms in bone and the soft tissue surrounding bone. cancer.gov/news-events/ca…

New findings from a large clinical trial could help doctors and patients select treatments for relapsed or treatment-resistant Ewing #sarcoma, a rare cancer that forms in bone and the soft tissue surrounding bone. cancer.gov/news-events/ca…
account_circle
NCICancerTrials(@NCICancerTrials) 's Twitter Profile Photo

NCI in the News: Can multi-cancer early detection tests save lives? NCI is launching a $75 million, 4-year pilot study to find out. science.org/content/articl… Philip E. Castle, Ph.D. @NCIPrevention News from Science

NCI in the News: Can multi-cancer early detection tests save lives? NCI is launching a $75 million, 4-year pilot study to find out. science.org/content/articl… @NCICastle @NCIPrevention @NewsfromScience #MCED
account_circle
NCICancerTrials(@NCICancerTrials) 's Twitter Profile Photo

A new study sheds light on the origin of an aggressive subtype of diffuse large B cell . The findings could help researchers develop more targeted therapies for this form of . ccr.cancer.gov/news/article/n…

A new study sheds light on the origin of an aggressive subtype of diffuse large B cell #lymphoma. The findings could help researchers develop more targeted therapies for this form of #BloodCancer. ccr.cancer.gov/news/article/n…
account_circle
NCICancerTrials(@NCICancerTrials) 's Twitter Profile Photo

Men diagnosed with low-risk are increasingly opting against immediate treatment and choosing active surveillance, a new study finds. Rates of active surveillance more than doubled between 2014 and 2021. cancer.gov/news-events/ca… UC San Francisco

Men diagnosed with low-risk #ProstateCancer are increasingly opting against immediate treatment and choosing active surveillance, a new study finds. Rates of active surveillance more than doubled between 2014 and 2021. cancer.gov/news-events/ca… @UCSF
account_circle
NCICancerTrials(@NCICancerTrials) 's Twitter Profile Photo

Researchers from NCI Center for Cancer Research and Herbert Irving Comprehensive Cancer Center have found that women of African ancestry have higher amounts of a protein called gp78 in their breast cancer tumors compared to women of European descent, leading to worse outcomes. ccr.cancer.gov/news/article/a…

Researchers from @NCIResearchCtr and @columbiacancer have found that women of African ancestry have higher amounts of a protein called gp78 in their breast cancer tumors compared to women of European descent, leading to worse outcomes. ccr.cancer.gov/news/article/a…
account_circle
NCICancerTrials(@NCICancerTrials) 's Twitter Profile Photo

A proposed rule prohibiting menthol flavoring is expected to make cigarettes less appealing, lower smoking rates, and reduce diseases and deaths caused by cigarette smoking. cancer.gov/news-events/ca…

A proposed rule prohibiting menthol flavoring is expected to make cigarettes less appealing, lower smoking rates, and reduce diseases and deaths caused by cigarette smoking. cancer.gov/news-events/ca… #TobaccoControl #CancerMoonshot
account_circle
NCICancerTrials(@NCICancerTrials) 's Twitter Profile Photo

Drugs widely used to treat certain autoimmune diseases improved survival for those hospitalized with , according to results from a large clinical trial led by NIH. nih.gov/news-events/ne…

Drugs widely used to treat certain autoimmune diseases improved survival for those hospitalized with #COVID19, according to results from a large clinical trial led by @NIH. nih.gov/news-events/ne…
account_circle
NCICancerTrials(@NCICancerTrials) 's Twitter Profile Photo

Two separate but complementary studies have identified a new way to classify meningioma, the most common type of . The system may help predict whether a patient’s tumor will grow back after treatment and may lead to new treatments. cancer.gov/news-events/ca…

Two separate but complementary studies have identified a new way to classify meningioma, the most common type of #BrainTumor. The system may help predict whether a patient’s tumor will grow back after treatment and may lead to new treatments. cancer.gov/news-events/ca…
account_circle
NCICancerTrials(@NCICancerTrials) 's Twitter Profile Photo

Check out what's new on NCI's websites, including the recently released Cancer Trends Progress Report and our freshly launched NCI Minute. cancer.gov/news-events/ca…

Check out what's new on NCI's websites, including the recently released Cancer Trends Progress Report and our freshly launched NCI Minute. cancer.gov/news-events/ca…
account_circle